National MS Society commits $14.2 Million to new MS research

The National MS Society has just committed more than $14.2 million to support 45 new MS research projects. These are part of a comprehensive approach to accelerate research breakthroughs aimed at stopping MS, restoring function that has been lost, and ending the disease forever.

This financial commitment is the latest in the Society’s relentless research effort, investing a projected $34 million in 2018 alone for new and ongoing studies around the globe. The Society stimulates studies worldwide, leverages opportunities, fosters collaboration, and shapes the research landscape to address the urgent needs of people with MS.

Just a few of the of the new cutting-edge research projects include two projects at Harvard’s Brigham and Women’s Hospital exploring the role of gut bacteria in MS; studies focusing ways to repair nerve-insulating myelin including one at University of California, San Francisco investigating the potential of repurposed medications to promote repair; and a team at the University of Washington testing non-pharmaceutical approaches to managing debilitating pain in MS.

“These new research projects and training awards strengthen the Society’s comprehensive approach addressing critical research and scientific workforce priorities. Focusing our investments on the most important unanswered questions will lead to breakthroughs for people with MS,” noted Bruce Bebo, PhD, National MS Society’s Executive Vice President, Research.

“These research dollars are raised by hundreds of thousands of dedicated people across the country who walk, run, bike, and even trek through mud at our events. We honor their efforts, as well as the efforts of all who write checks to support our mission,” said Cyndi Zagieboylo, the Society’s President and CEO. “We could not fund this important research without them.”

About Pharmascroll:

Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.

To read more news about Multiple Sclerosis, visit https://pharmascroll.com/news-category/multiple-sclerosis/

News Source: https://www.nationalmssociety.org/About-the-Society/News/National-MS-Society-Commits-$14-2-Million-to-New-R

Image Source: https://www.nmbu.no/en/research/funding